I hope that the truck trailer manufacturing community (and those who purchase from them) take a cue from the CMTA–a non-profit organization which is supporting an effective research strategy to find treatment for Charcot-Marie-Tooth, a hereditary disorder which multiple members of my family have.
CMTA has organized a collaborative process which brings together a global interdisciplinary team:
One of the most important ways the CMTA accelerates the research process is by putting together teams of top scientists recruited from an international body of scientific and clinical Key Opinion Leaders in CMT. The STAR program’s unique character stems from the willingness of the scientists to come together to advance CMT research collaboratively, sharing and communicating ideas, discoveries and research findings.
The CMTA’s funding and operations focus is on translational research that will lead as directly as possible to therapeutic treatments of CMT. To further this goal, the CMTA has put in place a STAR Advisory Board that includes both a Scientific Expert Board and a Therapy Expert Board. The CMTA’s STAR (Strategy to Accelerate Research)
This is the kind of strategy which we hope will be taking place at, and following, the Underride Roundtable on May 5, 2016, at the Insurance Institute for Highway Safety (IIHS) Vehicle Research Center in Ruckersville, Virginia.